# In-Stent Restenosis Post-Approval Study

> **NCT02542267** · NA · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 108 (actual)

## Conditions studied

- Peripheral Artery Disease
- Vascular Disease

## Interventions

- **DEVICE:** Gore VIABAHN Endoprosthesis

## Key facts

- **NCT ID:** NCT02542267
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-07
- **Final completion:** 2021-07
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02542267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02542267, "In-Stent Restenosis Post-Approval Study". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02542267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*